TACE combined with portal particle implantation in a case of stage IIIa primary hepatocellular carcinoma treated with sequential anlotinib

Few cases of patients with Cheng’s type III portal vein tumor thrombus (PVTT) have been reported to achieve radical cure without recurrence over time. In this study, we reported on a 55-year-old male patient with a diagnosis of stage IIIa China liver cancer staging (CNLC), PVTT Cheng’s type III, mil...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Cheng, Chen, Chen, Huang, Guiliu, Li, Yueyong, Zhao, Lifeng, Wei, Zhongheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548425/
https://www.ncbi.nlm.nih.gov/pubmed/37799127
http://dx.doi.org/10.5114/jcb.2023.131239
_version_ 1785115267286695936
author Lin, Cheng
Chen, Chen
Huang, Guiliu
Li, Yueyong
Zhao, Lifeng
Wei, Zhongheng
author_facet Lin, Cheng
Chen, Chen
Huang, Guiliu
Li, Yueyong
Zhao, Lifeng
Wei, Zhongheng
author_sort Lin, Cheng
collection PubMed
description Few cases of patients with Cheng’s type III portal vein tumor thrombus (PVTT) have been reported to achieve radical cure without recurrence over time. In this study, we reported on a 55-year-old male patient with a diagnosis of stage IIIa China liver cancer staging (CNLC), PVTT Cheng’s type III, mild cirrhosis, and chronic viral hepatitis B. TACE combined with radioactive iodine-125 ((125)I) particle implantation was applied to achieve radical treatment with sequential oral anlotinib hydrochloride capsules. This case might serve as a reference for the treatment of this disease.
format Online
Article
Text
id pubmed-10548425
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-105484252023-10-05 TACE combined with portal particle implantation in a case of stage IIIa primary hepatocellular carcinoma treated with sequential anlotinib Lin, Cheng Chen, Chen Huang, Guiliu Li, Yueyong Zhao, Lifeng Wei, Zhongheng J Contemp Brachytherapy Case Report Few cases of patients with Cheng’s type III portal vein tumor thrombus (PVTT) have been reported to achieve radical cure without recurrence over time. In this study, we reported on a 55-year-old male patient with a diagnosis of stage IIIa China liver cancer staging (CNLC), PVTT Cheng’s type III, mild cirrhosis, and chronic viral hepatitis B. TACE combined with radioactive iodine-125 ((125)I) particle implantation was applied to achieve radical treatment with sequential oral anlotinib hydrochloride capsules. This case might serve as a reference for the treatment of this disease. Termedia Publishing House 2023-08-31 2023-08 /pmc/articles/PMC10548425/ /pubmed/37799127 http://dx.doi.org/10.5114/jcb.2023.131239 Text en Copyright © 2023 Termedia https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/) )
spellingShingle Case Report
Lin, Cheng
Chen, Chen
Huang, Guiliu
Li, Yueyong
Zhao, Lifeng
Wei, Zhongheng
TACE combined with portal particle implantation in a case of stage IIIa primary hepatocellular carcinoma treated with sequential anlotinib
title TACE combined with portal particle implantation in a case of stage IIIa primary hepatocellular carcinoma treated with sequential anlotinib
title_full TACE combined with portal particle implantation in a case of stage IIIa primary hepatocellular carcinoma treated with sequential anlotinib
title_fullStr TACE combined with portal particle implantation in a case of stage IIIa primary hepatocellular carcinoma treated with sequential anlotinib
title_full_unstemmed TACE combined with portal particle implantation in a case of stage IIIa primary hepatocellular carcinoma treated with sequential anlotinib
title_short TACE combined with portal particle implantation in a case of stage IIIa primary hepatocellular carcinoma treated with sequential anlotinib
title_sort tace combined with portal particle implantation in a case of stage iiia primary hepatocellular carcinoma treated with sequential anlotinib
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548425/
https://www.ncbi.nlm.nih.gov/pubmed/37799127
http://dx.doi.org/10.5114/jcb.2023.131239
work_keys_str_mv AT lincheng tacecombinedwithportalparticleimplantationinacaseofstageiiiaprimaryhepatocellularcarcinomatreatedwithsequentialanlotinib
AT chenchen tacecombinedwithportalparticleimplantationinacaseofstageiiiaprimaryhepatocellularcarcinomatreatedwithsequentialanlotinib
AT huangguiliu tacecombinedwithportalparticleimplantationinacaseofstageiiiaprimaryhepatocellularcarcinomatreatedwithsequentialanlotinib
AT liyueyong tacecombinedwithportalparticleimplantationinacaseofstageiiiaprimaryhepatocellularcarcinomatreatedwithsequentialanlotinib
AT zhaolifeng tacecombinedwithportalparticleimplantationinacaseofstageiiiaprimaryhepatocellularcarcinomatreatedwithsequentialanlotinib
AT weizhongheng tacecombinedwithportalparticleimplantationinacaseofstageiiiaprimaryhepatocellularcarcinomatreatedwithsequentialanlotinib

Ejemplares similares